Systematic review / meta-analysis / 2011
Coffee consumption was linked to a lower risk of total cancer and several site-specific cancers in a meta-analysis of cohort studies.
A meta-analysis evaluated 59 prospective cohort studies across 40 independent cohorts to assess coffee intake and cancer risk. Compared with non- or seldom-drinkers, pooled relative risks were 0.87 (95% CI, 0.82-0.92) for regular drinkers, 0.89 (0.84-0.93) for low-to-moderate drinkers, and 0.82 (0.74-0.89) for high drinkers. An increase of 1 cup/day was associated with a 3% lower risk of cancer (RR 0.97; 95% CI, 0.96-0.98). Subgroup analyses identified inverse associations with bladder, breast, buccal/pharyngeal, colorectal, endometrial, esophageal, hepatocellular, leukemic, pancreatic, and prostate cancers.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of prospective cohort studies
- Who was studied
- 59 studies consisting of 40 independent cohorts
- What was measured
- Risk of cancer overall and site-specific cancers
THE PAPER
Coffee consumption and risk of cancers: a meta-analysis of cohort studies.
Yu X, Bao Z, Zou J, Dong J. BMC Cancer, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.